Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

Techniques such as Polymerase Chain Reaction (PCR), CRISPR-Cas9 gene editing, and recombinant DNA technology have ...

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

I previously compared the opportunities in CRISPR/Cas9 gene editing to be reminiscent of the golden years of biotech when ...

Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.

Good afternoon, ladies and gentlemen, and welcome everyone to the Maravai Life Sciences third-quarter 2024 earnings conference call. (Operator Instructions) I would now like to turn the call over to ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Hereditary Angioedema Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself ...